Authors: TSANTOULAS D VAFIADES J KRONBORG I LURIE Y VECELIC B STALGIS C

Citation: D. Tsantoulas et al., 4 WEEKS OF DAILY THERAPY WITH IFN-ALPHA-2B PLUS RIBAVIRIN FOLLOWED BYSTANDARD THERAPY IN GENOTYPE-3 - RESULTS AT 12 WEEKS, Hepatology, 28(4), 1998, pp. 1263-1263

Authors: VAGENA M DIMITROULOPOULOS D DEMONAKOU M PAOALOIS AE BERSOS G ARVANITAKIS P GALANOPOULOU P TSANTOULAS D

Citation: M. Vagena et al., DIFFERENT DOSES OF PARACETAMOL PRODUCED DIFFERENT TYPES OF LIVER-INJURY - AN EXPERIMENTAL-MODEL IN RABBITS, Hepatology, 28(4), 1998, pp. 1853-1853

Authors: KOSTOPANAGIOTOU G THEODORAKI K PYRSOPOULOS N RIGOPOULOU E DAFNIOS N PRACHALIAS A SMIRNIOTIS V TSANTOULAS D PAPADIMITRIOU J

Citation: G. Kostopanagiotou et al., HEMODYNAMIC-CHANGES IN ANHEPATIC VERSUS ISCHEMIC ACUTE LIVER-FAILURE EXPERIMENTAL-MODEL, Hepatology, 26(4), 1997, pp. 151-151

Authors: HADZIYANNIS SJ TSANTOULAS D RAPTOPOULOU M KITIS G VAFIADES E TASSOPOULOS NC AREIAS J MA M STEFFEN M VOGEL W STALGIS C DORAN Z GLUE P

Citation: Sj. Hadziyannis et al., INDUCTION DOSING WITH INTERFERON-ALPHA-2B - AN INTERNATIONAL STUDY, Hepatology, 26(4), 1997, pp. 1166-1166

Authors: DEMONAKOUVATOPOULOU M RIGOPOULOU E PYRSOPOULOS N KONTOGIANNI A TAMVAKIS N HATZAKIS A TSANTOULAS D

Citation: M. Demonakouvatopoulou et al., LIVER HISTOLOGY AND VIRAL LOAD IN ANTI-HCV POSITIVE INDIVIDUALS WITH NORMAL OR ABNORMAL ALT LEVELS, Hepatology, 26(4), 1997, pp. 1479-1479

Authors: TASSOPOULOS NC KARVOUNTZIS G TSANTOULAS D VAFIADI E HATZIS G AKRIVIADIS E SKOUTELIS A SIMOS A KEHAGIOGLOU K DELLADETSIMA I DEMONAKOU M KATSOULIDOU A SYPSA V HATZAKIS A

Citation: Nc. Tassopoulos et al., A MULTICENTER RANDOMIZED TRIAL OF 6-24 MONTH A-IFN THERAPY OF CHRONICHEPATITIS-C (CHC) DIRECTED BY SERUM HCV RNA - FIRST INTERIM ANALYSIS, Hepatology, 26(4), 1997, pp. 1939-1939